Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing
articles matching Liver function — open any to read the full text,
or download the PDF or XML.
Feb 2025 DOI 10.14302/issn.2326-0793.jpgr-25-5405
Alcohol use disorder (AUD) is the most prevalent substance use disorder. Excessive alcohol consumption leads to a range of health issues. We set out to identify inflammatory markers linked to alcohol consumption, which might ultimately offer novel insight into genetic underpinnings and have implications for alcohol-associated disease. Alcohol consumption and blood-based multi-omics data were collected by The Mayo Clinic Center for Individualized Treatment of Alcohol Dependence study. Plasma samples from patients with AUD were used for proteomics analysis using the OLINK “Explore Inflammation” panel (n=410). Liver enzymes were also measured. A genome-wide association study (GWAS) was performed to explore the relationship between genetic variants and plasma TREM2 levels. Our findings show thatplasma triggering receptor expressed on myeloid cells 2 (TREM2), a key gene associated with neurodegenerative disease, was the most significant signal correlated with alcohol consumption, and has also been associated with liver enzyme levels in patients with AUD. We identified the rs7232 single nucleotide polymorphism (SNP) in MS4A6A as a key genetic variant associated with plasma TREM2 levels, with the minor allele (A) linked to higher TREM2 levels and increased alcohol consumption, particularly in men. Furthermore, MA4A6A is an ethanol-responsive gene in a SNP-dependent manner, and the variant genotype of the rs7232 SNP was associated with lower expression for MA4A6A due to proteasome-mediated protein degradation. In summary, this study provides insight into the relationship between plasma TREM2 levels, alcohol consumption, and liver function in AUD patients, shedding light on genetic factors underlying alcohol-related diseases.
Jul 2021 DOI 10.14302/issn.2577-2279.ijha-21-3869
Rotenone is well known environmental neurotoxin used to induce Parkinson’s disease (PD) model. Numerous studies are investigated its toxicity on the brain but few studies are available that examined its toxicity on the liver and kidney. Therefore, the main aim of the present work was to explore the toxicity of rotenone on the liver and kidney and its protection through quercetin. Administration of rotenone orally at the dose of (5mg/kg b.w daily for 60 days) caused a significant increase in the levels of liver function and renal function biomarkers as compared to controls. A significant increase in the level of lipid peroxidation, nitric oxide, and decrease in the levels of reduced glutathione, reduction in the activities of catalase and superoxide dismutase were observed in the liver and kidney as compared to control. The histopathological and SEM study in rotenone-treated mice showed alteration and signs of inflammation in the liver and kidney. While co-treatment of quercetin orally (30 mg/kg b.w for 60 days) together with rotenone, reversed the above parameters. In conclusion, rotenone significantly damages the liver and kidney, and the administration of quercetin along with rotenone shown a protective role. This study provides a new insight into where rotenone-induced liver and kidney dysfunction could be successfully protected by quercetin.
Mar 2020 DOI 10.14302/issn.2577-2279.ijha-20-3232
Objective Exposure of dichlorvos-contaminated foods, water and environment can lead to decrease in proper liver function. Thus, Mimosa pudica(MP)is being investigated in the present study to determine its protective effect on dichlorvos induced hepatotoxity in Mice. Methods Fifty adult male BALB/c mice weighing between 20-30g were randomly assigned into 5 groups of 10 animals each (Groups A, B, C, D, and E). Group A as the control Group received normal feed, group B received 0.1 ml of MP, group C was given 40 g of 2.5% Dichlorvos (DDVP) for 28 days. While, group D were given 40 g of 2.5% DDVP with 0.1ml of MP and group E animals were given DDVP for half the period of administration, normal feed and 0.1ml MP for 14 days. Histological and biochemical preparations of the liver were processed and data were expressed as mean± SEM. Significant difference was set at p<0.05. Results ALT activity and the total protein level of the liver show no significant increase (P < 0.005) when compared with the control. AST and ALP activities were significantly increased in animals given DDVP with subsequent MP treatment when compared with the controls. Histological studies revealed distortion of normal hepatic histoarchitecture in DDVP group B and MP groups mitigated these changes in the treated groups. Conclusion Dichlorvos caused tissue distortion in the mice with prominent toxic effects on the liver while MP extract showed ameliorative effects on the liver that was exposed to DDVP